Dmg Group, LLC Abbott Laboratories Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dmg Group, LLC holds 4,053 shares of ABT stock, worth $469,742. This represents 0.38% of its overall portfolio holdings.

Number of Shares

4,053

Previous 4,467 9.27%

Holding current value

$469,742

Previous $464,000 0.43%

% of portfolio

0.38%

Previous 0.4%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $41,428 - $48,905	-414 Reduced 9.27%	4,053 $462,000
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $29,715 - $33,169	-295 Reduced 6.19%	4,467 $464,000
Q1 2024 Apr 19, 2024	BUY	$109.52 - $120.96 $81,373 - $89,873	743 Added 18.49%	4,762 $541,000
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $127,709 - $156,326	-1,416 Reduced 26.05%	4,019 $442,000
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $5,349 - $6,418	-56 Reduced 1.02%	5,435 $526,000
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $6,853 - $7,635	-68 Reduced 1.22%	5,491 $598,000
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $10,848 - $12,769	-112 Reduced 1.97%	5,559 $565,000
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $19,677 - $23,084	-207 Reduced 3.52%	5,671 $621,000
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $53,605 - $62,064	-554 Reduced 8.61%	5,878 $585,000
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $65,222 - $78,833	-639 Reduced 9.04%	6,432 $706,000
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $2,280 - $2,780	20 Added 0.28%	7,071 $846,000
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $814,602 - $997,434	7,051 New	7,051 $849,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account